BioHaven (BHVN) buyer 1500 January $62.5/$80 call spreads for $4.25, strong mover from prior bull flows and insider buys, BAML moved myostatin probability of success to 60% from 45%, peak global sales of $780M with upside depending on strength of Biohaven’s Phase 3 data